| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.7 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.067 | 0.7 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |